COVID-19 Vaccine Hesitancy in the French Population of Working Age: A Randomized Experiment of Vaccine Characteristics

2020 ◽  
Author(s):  
Michaël Schwarzinger ◽  
Verity Watson ◽  
Pierre Arwidson ◽  
François Alla ◽  
Stéphane Luchini
Keyword(s):  
Vaccine Hesitancy ◽  
Randomized Experiment ◽  
French Population ◽  
Working Age

Sharp rise in vaccine hesitancy in a large and representative sample of the French population: reasons for vaccine hesitancy.

2020 ◽  
Author(s):  
Anne-Sophie Hacquin ◽  
Sacha Altay ◽  
Emma de Araujo ◽  
Coralie Chevallier ◽  
Hugo Mercier
Keyword(s):  
At Risk ◽  
Educational Level ◽  
Representative Sample ◽  
Vaccine Hesitancy ◽  
The Political ◽  
French Population ◽  
Sharp Rise ◽  
Vaccine Refusal ◽  
French People ◽  
Nationally Representative

A safe and effective COVID-19 vaccine is our only hope to decisively stop the spread of the SARS-CoV-2. But a vaccine will only be fully effective if a significant share of the population agrees to get it. Five consecutive surveys of a large, nationally representative sample (N = 1000 for each wave) surveyed attitudes towards a future COVID-19 vaccine in France from May 2020 to October 2020. We found that COVID-19 vaccine refusal has steadily increased, reaching an all-time high with only 23% of participants willing to probably or certainly take a future COVID-19 vaccine in September 2020. Vaccine hesitant individuals are more likely to be women, young, less educated, to vote at the political extremes, to be dissatisfied with the government’s response to the COVID-19 crisis, and to feel less at risk of COVID-19. The reasons why French people would refuse to take the COVID-19 vaccine are similar to those offered for other vaccines, and these reasons are strikingly stable across gender, age and educational level. Finally, most French people declare they would not take the vaccine as soon as possible but would instead rather wait or not take it at all.

scholarly journals Population perception of mandatory childhood vaccination programme before its implementation, France, 2017

2019 ◽  
Vol 24 (25) ◽  
Author(s):  
Pauline Mathieu ◽  
Arnaud Gautier ◽  
Jocelyn Raude ◽  
Thomas Goronflot ◽  
Titouan Launay ◽  
...  
Keyword(s):  
Positive Opinion ◽  
Childhood Vaccination ◽  
World Health ◽  
Vaccine Hesitancy ◽  
Advisory Group ◽  
French Population ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Factors Associated ◽  
Vaccines For Children

Background Vaccination policy in France was previously characterised by the coexistence of eight recommended and three mandatory vaccinations for children younger than 2 years old. These 11 vaccines are now mandatory for all children born after 1 January 2018. Aim To study the French population’s opinion about this new policy and to assess factors associated with a positive opinion during this changing phase. Methods A cross-sectional survey about vaccination was conducted from 16 November–19 December 2017 among the GrippeNet.fr cohort. Data were weighted for age, sex and education according to the French population. Univariate and multivariate analyses were performed to identify factors associated with a favourable opinion on mandatory vaccines’ extension and defined in the ‘3Cs’ model by the World Health Organization Strategic Advisory Group of Experts working group on vaccine hesitancy. Results Of the 3,222 participants (response rate 50.5%) and after adjustment, 64.5% agreed with the extension of mandatory vaccines. It was considered a necessary step by 68.7% of the study population, while 33.8% considered it unsafe for children and 56.9% saw it as authoritarian. Factors associated with a positive opinion about the extension of mandatory vaccines were components of the confidence, complacency and convenience dimensions of the ‘3Cs’ model. Conclusions In our sample, two thirds of the French population was in favour of the extension of mandatory vaccines for children. Perception of vaccine safety and benefits were major predictors for positive and negative opinions about this new policy.

scholarly journals Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law

2018 ◽  
Vol 23 (17) ◽  
Author(s):  
Daniel Lévy-Bruhl ◽  
Jean-Claude Desenclos ◽  
Sylvie Quelet ◽  
François Bourdillon
Keyword(s):  
Hepatitis B ◽  
Vaccine Coverage ◽  
Steering Committee ◽  
Historical Background ◽  
Vaccine Hesitancy ◽  
Influenza B ◽  
French Population ◽  
Haemophilus Influenza ◽  
Child Services ◽  
The Law

On 4 December 2017, French parliamentarians passed a law extending the vaccination mandates for children up to 2 years of age from three vaccinations (against diphtheria, tetanus and poliomyelitis) to 11 by adding vaccinations against pertussis, Haemophilus influenza b (Hib), hepatitis B, pneumococcal diseases, meningococcal C diseases, measles, mumps and rubella. This vote follows a recommendation made by the Steering Committee of the Citizen Consultation on Vaccination that took place in 2016. The law applies to all children born after 1 January 2018. Parents who do not fulfil the mandate will not be fined but non-vaccinated children will not be admitted to any collective child services such as nurseries or schools. No exemption other than for medical reasons will be considered. Here we describe the historical background of this evolution and its main epidemiological, sociological and policy drivers. They mainly refer to insufficient vaccine coverage, persistence of a preventable burden for some diseases and growing vaccine hesitancy in the French population. We also discuss some of the challenges and conditions of success.

scholarly journals Vaccine hesitancy among working-age adults with/without disability in the UK

Public Health ◽  
2021 ◽  
Vol 200 ◽  
pp. 106-108
Author(s):  
E. Emerson ◽  
V. Totsika ◽  
Z. Aitken ◽  
T. King ◽  
R.P. Hastings ◽  
...  
Keyword(s):  
Vaccine Hesitancy ◽  
Working Age ◽  
The Uk

scholarly journals Surfacing norms to increase vaccine acceptance

2021 ◽  
Author(s):  
Alex Vernon Moehring ◽  
Avinash Collis ◽  
Kiran Garimella ◽  
M. Amin Rahimian ◽  
Sinan Aral ◽  
...  
Keyword(s):  
Vaccine Hesitancy ◽  
Accurate Information ◽  
Randomized Experiment ◽  
Relative Importance ◽  
Descriptive Norms ◽  
Vaccine Acceptance ◽  
Human Behaviors ◽  
Positive Effects ◽  
Present Information ◽  
Successful Control

Despite the availability of multiple safe vaccines, vaccine hesitancy may present a challenge to successful control of the COVID-19 pandemic. As with many human behaviors, people's vaccine acceptance may be affected by their beliefs about whether others will accept a vaccine (i.e., descriptive norms). However, information about these descriptive norms may have different effects depending on people's baseline beliefs and the relative importance of conformity, social learning, and free-riding.Here, using a large, pre-registered, randomized experiment (N=305,694) embedded in an international survey, we show that accurate information about descriptive norms can substantially increase intentions to accept a vaccine for COVID-19. These positive effects (e.g., reducing by 5% the fraction of people who are "unsure" or more negative about accepting a vaccine) are largely consistent across the 23 included countries, but are concentrated among people who were otherwise uncertain about accepting a vaccine. Providing this normative information in vaccine communications partially corrects individuals' apparent underestimation of how many other people will accept a vaccine. These results suggest that public health communications should present information about the widespread and growing intentions to accept COVID-19 vaccines.

scholarly journals Regional Differences in COVID-19 Vaccine Hesitancy in December 2020: A Natural Experiment in the French Working-Age Population

Vaccines ◽  
2021 ◽  
Vol 9 (11) ◽  
pp. 1364
Author(s):  
Fanny Velardo ◽  
Verity Watson ◽  
Pierre Arwidson ◽  
François Alla ◽  
Stéphane Luchini ◽  
...  
Keyword(s):  
Vaccination Campaign ◽  
Infection Risk ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Attitudinal Factors ◽  
Vaccine Manufacturer ◽  
Mass Vaccination Campaign ◽  
Working Age ◽  
Initial Setting ◽  
East West

It can be assumed that higher SARS-CoV-2 infection risk is associated with higher COVID-19 vaccination intentions, although evidence is scarce. In this large and representative survey of 6007 adults aged 18–64 years and residing in France, 8.1% (95% CI, 7.5–8.8) reported a prior SARS-CoV-2 infection in December 2020, with regional variations according to an East–West gradient (p < 0.0001). In participants without prior SARS-CoV-2 infection, COVID-19 vaccine hesitancy was substantial, including 41.3% (95% CI, 39.8–42.8) outright refusal of COVID-19 vaccination. Taking into account five characteristics of the first approved vaccines (efficacy, duration of immunity, safety, country of the vaccine manufacturer, and place of administration) as well as the initial setting of the mass vaccination campaign in France, COVID-19 vaccine acceptance would reach 43.6% (95% CI, 43.0–44.1) at best among working-age adults without prior SARS-CoV-2 infection. COVID-19 vaccine acceptance was primarily driven by vaccine characteristics, sociodemographic and attitudinal factors. Considering the region of residency as a proxy of the likelihood of getting infected, our study findings do not support the assumption that SARS-CoV-2 infection risk is associated with COVID-19 vaccine acceptance.

scholarly journals COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

2021 ◽  
Vol 6 (4) ◽  
pp. e210-e221 ◽  
Author(s):  
Michaël Schwarzinger ◽  
Verity Watson ◽  
Pierre Arwidson ◽  
François Alla ◽  
Stéphane Luchini
Keyword(s):  
Vaccine Hesitancy ◽  
Survey Experiment ◽  
Working Age ◽  
Working Age Population

scholarly journals Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance

2018 ◽  
Vol 23 (17) ◽  
Author(s):  
Dominique Rey ◽  
Lisa Fressard ◽  
Sébastien Cortaredona ◽  
Aurélie Bocquier ◽  
Arnaud Gautier ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Elderly People ◽  
Perceived Risk ◽  
Multivariable Analysis ◽  
Vaccine Uptake ◽  
World Health ◽  
Vaccine Hesitancy ◽  
Human Papillomavirus Vaccine ◽  
French Population ◽  
Cross Sectional

Background Vaccine hesitancy (VH) is prominent in France. Objectives: This study aimed to estimate the prevalence and socio-demographic correlates of VH in sub-groups of the French population and to investigate the association of VH with both vaccine uptake and perceived risk–benefit balance (RBB) for four vaccines. Methods: During the 2016 Health Barometer – a national cross-sectional telephone survey in a representative sample of the French population – parents of 1–15 year-old children, parents of 11–15 year-old girls and elderly people aged 65–75 years were asked about VH (using three questions adapted from the World Health Organization definition), vaccine uptake and perceived RBB for measles and hepatitis B (children’s parents), human papillomavirus (girls’ parents) and seasonal influenza (elderly people) vaccines. Results: A total of 3,938 parents including 959 girls' parents – and 2,418 elderly people were interviewed. VH prevalence estimates were 46% (95% confidence interval (CI): 44–48) among parents, 48% (95%CI: 45–51) among girls’ parents and 35% (95% CI: 33–36) among elderly people, with higher estimates associated with high education level, children’s age (10–15 years), and, for the elderly, poor perception of health status. VH was associated with uncertainty about and/or an unfavourable perception of vaccines’ RBB for the four vaccines and with lower self-reported vaccine uptake, except for human papillomavirus vaccine in girls. Results were confirmed by multivariable analysis. Conclusion: Further research is needed to study the association between VH and vaccine uptake for other vaccines, and to design and validate measurement tools to monitor VH over time.

Sign in / Sign up

Export Citation Format

Share Document